What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Identify whether a Backdoor Roth is right for you, focusing on income, taxes, and long-term retirement goals.
23,905 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
When a member of the texas capital bancshares board makes a sizable purchase, it often prompts questions from investo...
Investing headlines love bold predictions, but long-term numbers rarely align with hype. This guide uses SpaceX as a ...
A sharp 178% EPS rise is grabbing attention, paired with an insider stock sale at Rogers Corp. This article breaks do...
Defense-tech pioneer Palmer Luckey calls for public-oversight over AI, arguing government power should guide how AI i...
When a CFO buys a sizable block of shares, it can hint at confidence in the company’s future. This article breaks dow...
A Workday insider recently sold a sizable block of shares. This article breaks down what that signals for investors, ...
Is Bloom Energy a buy, sell, or hold in 2026? This guide breaks down the business, potential catalysts, and key risks...
When a COO sells a hefty block of stock as the market rewards the company with an big run, investors should look beyo...
Copart director Daniel Englander recently sold 80,000 shares for about $2.2 million. With CPRT down roughly 40%, inve...
QuantumScape faces a volatile path from lab breakthroughs to mass production. This guide breaks down what the stock d...
Super Micro Computer stunned investors with a colossal AI server backlog, but a planned $7 billion capital raise trig...